Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
BIZ.BK
Strong BuyFull HouseBusiness Alignment Public Company Limited · Healthcare · Thailand · $111M · Avg Vol: $45K/d
COMPANY DESCRIPTION
Business Alignment Public Company Limited sells medical equipment in Thailand. It operates through two segments, Sales of medical equipment and Hospital operations.
FINANCIAL SUMMARY (THB)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 1.2B | 1.7B | 1.7B | 2.0B | 18.2% | 2.5B |
| EPS (THB) | 0.22 | 0.33 | 0.37 | 0.51 | 32.3% | 0.73 |
| Shares | 600.7M | 600.7M | 600.7M | 600.7M | 0.0% | 600.7M |
| Debt | 222.6M | 111.8M | 158.6M | 362.7M | 17.7% | 342.6M |
| Equity | 752.8M | 834.0M | 878.3M | 973.4M | 8.9% | — |
| Op CF | 218.7M | 647.2M | -63.8M | -250.1M | 195.9% | 189.8M |
| Inv CF | 4.9M | -13.3M | -15.8M | 36.0M | — | — |
| Fin CF | -312.9M | -243.0M | -145.6M | -24.2M | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of BIZ.BK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| BIZ.BK | Business Alignment Public Company Limited(you) | $111M | 100 | Strong Buy |
| RJH.BK | Rajthanee Hospital Public Company Limited | $135M | 95 | Strong Buy |
| VIH.BK | Srivichaivejvivat Public Company Limited | $160M | 98 | Strong Buy |
| IP.BK | Inter Pharma Public Company Limited | $90M | 93 | Strong Buy |
| TOG.BK | Thai Optical Group Public Company Limited | $102M | 90 | Strong Buy |
| EKH.BK | Ekachai Medical Care Public Company Limited | $127M | 88 | Strong Buy |
| NTV.BK | Nonthavej Hospital Public Company Limited | $93M | 89 | Strong Buy |
| RPH.BK | Ratchaphruek Hospital Public Company Limited | $79M | 89 | Strong Buy |
| TNH.BK | Thai Nakarin Hospital Public Company Limited | $156M | 79 | Buy |
| CHG.BK | Chularat Hospital Public Company Limited | $519M | 95 | Strong Buy |
Peer medians: ROE 12.0% · P/E 15.4x · Gross margin 28.4%